โ† All deals

Conexeu Sciences Inc.

BiotechnologyBiotechnologyRegenerative MedicineTissue Regeneration
๐Ÿ“ Reno, NV, United States
StreetZero Signal 62
Be the first to signal interest

About Conexeu Sciences Inc.

Conexeu Sciences Inc. is a biotechnology company based in Reno, Nevada, focused on revolutionizing tissue regeneration through its patented collagen flowable gel platform. Emerging from over a decade of university research, the company is advancing regenerative medicine with potential applications in wound care, veterinary medicine, 3D bioprinting, and dental soft tissue repair. It recently completed a $5 million Regulation Crowdfunding financing via the Equifund platform.

LATEST FUNDINGPrivate Placement
$22K
Announced 2026-11-05
TOTAL RAISED$5M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Conexeu Sciences Inc..

Free plan includes 3 full deal profiles every month.

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • Completed maximum $5M Reg CF financing via Equifund platform in under two weeks.
  • Developing patented collagen flowable gel platform from over a decade of university research.
  • Targeting applications in wound care, veterinary medicine, 3D bioprinting, and dental repair.
  • Operates in regenerative medicine and biotechnology sectors with B2B, B2D, and D2C models.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account